Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gynecology
  3. Postoperative pain: a question of gut microbiota?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Gynecology
  3. Postoperative pain: a question of gut microbiota?
Gynecology

Postoperative pain: a question of gut microbiota?

Cancer
Gynecology Gastroenterology General Medicine

While previous work has linked the diversity and composition of the gut microbiota to postoperative pain after wrist surgery, a team has now identified for the first time bacteria associated with the presence or absence of persistent post-surgical pain following breast cancer surgery.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 30 September 2024
Updated 10 February 2025

Persistent post-surgical pain (or  (sidenote: Persistent post-surgical pain (PPSP) Pain which continues after a surgical operation in a significant form for at least three months, and is not related to pre-existing painful conditions ) ) is as common as it is underestimated: it affects millions of patients worldwide. Predisposing factors include the type of surgery. For example, in the case of breast cancer, 80% of women whose surgery includes axillary lymph node clearance suffer from PPSP.

Previous studies have implicated the gut microbiota in postoperative pain. However, the mechanisms remained unclear: gut dysbiosis could induce an imbalance in the production of microbial metabolites, and play a role in the development of PPSP via (sidenote: Gut-brain axis Two-way communication network between the gut and the brain, which allows the gut and brain to communicate via three different pathways: 
1. the neuronal pathway (neurons), mainly via the vagus nerve and the enteric nervous system,
2. the endocrine pathway, by secreting hormones such as cortisol, adrenaline and serotonin
3. the immune system pathway, by modulating cytokines The gut-brain axis influences our behavior, cognition (memory), emotions, moods, desires, perception... and pain, among other things.
)
.

Everything you need to know about the microbiota gut-brain axis 22.05.2023 Everything you need to know about the microbiota gut-brain axis Read more

To find out more, Irish researchers at University College Cork 1 conducted a prospective observational study of adult patients undergoing surgery for breast cancer (excluding axillary clearance or reconstructive surgery, which are very painful). Their aim was to determine whether the composition of the gut microbiota was associated with the incidence and extent of PPSP in this cohort of patients.

2.3 million In 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths globally ²

most common cancer Breast cancer was the most common cancer in women in 157 countries out of 185 in 2022 ²

Approximately 99% des cancers du sein surviennent chez les femmes, contre 0,5 à 1 % chez les hommes ²

Less alpha diversity

Twelve weeks after the operation, 21 patients (51.2%) reported no pain, while 20 (48.8%) reported persistent pain. This difference seemed to be linked to the diversity of their gut microbiota: a lower (sidenote: Alpha diversity Number of species coexisting in a given environment ) (3 measures: richness, Shannon index and Simpson index) was observed in patients reporting severe pain 1 hour after surgery and 12 weeks later, compared to those reporting mild pain. On the other hand, there was no difference in (sidenote: Beta diversity Rate of variation in species composition, calculated by comparing the number of unique taxa in each ecosystem ) .

13.09.2024 Breast cancer: a bacterium in the intratumoral microbiota is involved in chemoresistance Read more

Bacteria associated with the presence or absence of pain

But above all, the team highlighted stark differences in the composition of the gut microbiota corresponding to pain, with increased presences of:

  • Bifidobacterium longum and Faecalibacterium prausnitzii in women who reported no pain 12 weeks after surgery
  • Megamonas hypermegale, Bacteroides pectinophilus, Ruminococcus bromii and Roseburia hominis in women with PSPP.

These results seem to support those of previous studies: reduction in the relative abundance of Faecalibacterium prausnitzii in patients with fibromyalgia; reduction of pain after the administration of Bifidobacterium longum in a rat model with arthritis. There is one exception, however: Roseburia hominis reduced visceral hypersensitivity in rats, while it was associated with the presence of PPSP in this study.

While these relationships between microbiota and PSPP are a first, the authors caution that they are only correlations and not causal links.

Sources

1. Masaud K, Collins JM, Rubio RC et al. The gut microbiota in persistent post-operative pain following breast cancer surgery. Sci Rep. 2024 May 30;14(1):12401.

2. https://www.who.int/fr/news-room/fact-sheets/detail/breast-cancer

Tags
Cancer Breast cancer Gut microbiota Women health Microbiome Flora

    See also

    Breast cancer, antibiotics and gut microbiota: a losing combination
    Actu PRO : Cancer du sein : l’efficacité de l’immunothérapie déterminée par le microbiote intestinal ? Breast cancer: efficacy of immunotherapy conditioned by the gut microbiota?
    Created 30 September 2024
    Updated 10 February 2025

    About this article

    To know more about this topic.

    Main topic

    Cancer

    Medical practice

    Gynecology Gastroenterology General Medicine

    Content type

    News

    Continue reading

    News
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    09.04.2024

    Climate change: two articles warn of the dangers to human health

    Read the article
    18.04.2024

    Role of glyphosate in disrupting the microbiota-gut-brain axis

    Read the article
    16.12.2024

    Oral microbiota transplantation: a ray of hope for preventing chemotherapy-induced mucositis?

    Read the article
    13.09.2024

    Breast cancer: a bacterium in the intratumoral microbiota is involved in chemoresistance

    Read the article

    Commensal clostridiales strains mediate effective anti-cancer immune response against solid tumours

    COMMENTED ARTICLE - ADULTS’ SECTION By Pr. Harry S...

    Find out more

    Focus on the 2018 GMFH

    Congress review By Dr. Julien Scanzi Hepato-gastroenterology, Estaing University Hospital of Clermon...

    Find out more
    Actu PRO: Immunothérapie et cancer : pas d’antibiothérapie préalable
    16.12.2019

    Cancer immunotherapy: no prior antibiotic treatment

    Read the article
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo